Alyeska Investment Group
RVLP

Alyeska Investment Group’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Alyeska Investment Group’s Portfolio RVLP Stock Details RVLP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,125,689
Closed -$1.22M – 695
2021
Q4 		$1.22M Buy
+1,125,689
New +$1.83M 0.01% 498

Other funds holding RVLP

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
RA
Rovida Advisors Fort Lauderdale, Florida $116M AUM 12.52% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MWM
Marietta Wealth Management Marietta, Georgia $841M AUM 21.92% 1-Year Est. Return
TC
Titleist Capital San Antonio, Texas $427M AUM 24.17% 1-Year Est. Return

Alyeska Investment Group's RVLP Position: Q1 2022 in Review

Alyeska Investment Group sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q1 2022, closing a stake of 1,125,689 shares — an estimated $1.22M sold.

Alyeska Investment Group first reported a position in RVLP in Q4 2021 and held it in 1 quarter. The position peaked at $1.22M in Q4 2021. 36 funds tracked by Wall St. Rank hold RVLP as of Q1 2022.

  • Alyeska Investment Group reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q1 2022 after selling out during the quarter.
  • Alyeska Investment Group sold 1,125,689 RVL Pharmaceuticals plc Ordinary Shares shares in Q1 2022, an estimated $1.22M.
  • Alyeska Investment Group first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q4 2021 and held it in 1 quarter.
  • Alyeska Investment Group's RVL Pharmaceuticals plc Ordinary Shares position peaked at $1.22M in Q4 2021.
  • 36 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q1 2022.

Based on Alyeska Investment Group's 13F filing for Q1 2022, filed 16 May 2022.